Profound Medical Announces Voting Results from the 2021 Annual Meeting of Shareholders and Management Changes
19 mai 2021 16h30 HE
|
Profound Medical Corp.
TORONTO, May 19, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual Meeting of...
Profound Medical Announces First Quarter 2021 Financial Results
12 mai 2021 16h13 HE
|
Profound Medical Corp.
TORONTO, May 12, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical and Akumin Enter into U.S. Multi-Center Commercial Agreement for TULSA-PRO®
06 mai 2021 07h00 HE
|
Profound Medical Corp.
TORONTO, May 06, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Release First Quarter 2021 Financial Results on May 12 – Conference Call to Follow
21 avr. 2021 16h30 HE
|
Profound Medical Corp.
TORONTO, April 21, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Participate in the 2021 Bloom Burton & Co. Virtual Healthcare Investor Conference
14 avr. 2021 16h30 HE
|
Profound Medical Corp.
TORONTO, April 14, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces the Appointment of Cynthia Lavoie to its Board of Directors
03 mars 2021 07h00 HE
|
Profound Medical Corp.
TORONTO, March 03, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable,...
Profound Medical Announces Fourth Quarter and Full Year 2020 Financial Results
02 mars 2021 16h02 HE
|
Profound Medical Corp.
TORONTO, March 02, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Participate in March Virtual Investor Conferences
25 févr. 2021 16h30 HE
|
Profound Medical Corp.
TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free...
Profound Medical to Participate in the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
11 févr. 2021 16h30 HE
|
Profound Medical Corp.
TORONTO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free...
Profound Medical to Release Fourth Quarter and Full Year 2020 Financial Results on March 2 – Conference Call to Follow
09 févr. 2021 16h30 HE
|
Profound Medical Corp.
TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free...